Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
UNCY
UNCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
UNCY News
Unicycive's Drug Application Accepted by FDA with Target Date Set
Jan 29 2026
Newsfilter
Unicycive's Kidney Disease Therapy NDA Accepted by FDA
Jan 29 2026
seekingalpha
Unicycive's Drug Application Accepted by FDA
Jan 29 2026
Newsfilter
Unicycive Resubmits NDA for OLC to Treat Hyperphosphatemia in CKD Patients
Dec 29 2025
NASDAQ.COM
Unicycive Resubmits OLC NDA to FDA, Cash Runway Until 2027
Dec 29 2025
Globenewswire
Unicycive Resubmits OLC NDA to FDA, Cash Runway Until 2027
Dec 29 2025
Newsfilter
Quantum Corp Faces Investigation Over Financial Misstatements
Dec 18 2025
Globenewswire
Five Below (FIVE) Class Action Survives Dismissal Motion Amid Securities Fraud Allegations
Dec 03 2025
Globenewswire
Cytokinetics Faces Shareholder Investigation Over Alleged Misstatements
Dec 02 2025
Globenewswire
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
Crucial Update for Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR), Five Below, Inc. (NASDAQ: FIVE), Maison Solutions Inc. (NASDAQ: MSS), and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Looking into Claims for You
Nov 14 2025
Globenewswire
Bragar Eagel & Squire Launches Investigation into Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus for Long-Term Stockholders; Invites Investors to Reach Out to the Firm
Nov 13 2025
Globenewswire
Unicycive Therapeutics Reports GAAP EPS of -$0.46, Exceeding Estimates by $0.07
Nov 12 2025
SeekingAlpha
Crucial Update for Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR), Five Below, Inc. (NASDAQ: FIVE), Molina Healthcare, Inc. (NYSE: MOH), and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Looking into Claims for You
Nov 10 2025
Globenewswire
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Investigates Unicycive Therapeutics, Inc. for Long-Term Stockholders and Urges Investors to Reach Out to the Firm
Oct 31 2025
Globenewswire
Unicycive Therapeutics to Present New Data Highlighting the Promise of Oxylanthanum Carbonate for Hyperphosphatemia Treatment at the 2025 American Society of Nephrology Kidney Week Conference
Oct 30 2025
Newsfilter
Show More News
